Centogene_Logo.png
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
15 mai 2024 17h17 HE | Centogene NV
Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned...
Centogene_Logo.png
CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
30 mars 2022 07h30 HE | Centogene NV
- Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments, Exceeds Guidance - Focus on Pharma and Diagnostics to Position for Strong Performance in 2022 - Closed $62 Million...